J&J Unit Loses Out To Medtronic In Stent Case

Law360, New York (March 23, 2006, 12:00 AM EST) -- In a big upset for Johnson & Johnson, an arbitration panel has ruled that a Medtronic Inc. coronary stent does not infringe on its rival’s patents, giving Medtronic the opportunity to take a large bite out of the $5 billion global stent market.

The independent panel found Wednesday that Medtronic’s Driver stent did not violate a 1997 settlement and cross-license agreement with patents of Johnson & Johnson’s Cordis unit.

The arbitration panel found its devices were licensed under the agreement between Medtronic and Cordis for the...
To view the full article, register now.